U. Fink
U. Fink publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Gastroenterology, on topics such as Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment and Colorectal Cancer Treatments and Studies.
- World rank
- #1,234,025 of 1,633,909 ranked researchers
- Rank in Germany
- #69,713 of 86,443
- Works
- 18
- Citations
- 11
- Citations per work
- 0.6
What does U. Fink research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Pulmonary and Respiratory Medicine27% of their works
- 2Oncology19% of their works
- 3Gastroenterology8% of their works
- 4Surgery8% of their works
- 5Radiology, Nuclear Medicine and Imaging8% of their works
- 6Ophthalmology8% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Treatments and Studies
- Lung Cancer Treatments and Mutations
- Esophageal Cancer Research and Treatment
- Advanced X-ray and CT Imaging
- Chemotherapy-related skin toxicity
- Pituitary Gland Disorders and Treatments
Which keywords describe U. Fink's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Gastric Cancer, Molecular Characterization, Cetuximab, EGFR Mutations, Esophageal Carcinoma and Imatinib Mesylate.
- Pituitary Adenomas
- Extravasation
- Dermatological Toxicity
- Targeted Therapy
- Preoperative Chemoradiotherapy
- Imatinib Mesylate
- EGFR Mutations
- Molecular Characterization
- Endoscopic Resection
- Chemotherapy
- Gastric Cancer
- Cetuximab
- Esophageal Carcinoma
- KRAS Mutations
- Sunitinib
- Cushing's Syndrome
- Dual-Energy CT
- Material Differentiation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Chemotherapy63 topics
- Endoscopic Resection52 topics
- Gastric Cancer31 topic
- Molecular Characterization31 topic
- Cetuximab21 topic
- EGFR Mutations21 topic
- Esophageal Carcinoma21 topic
- Imatinib Mesylate21 topic
- KRAS Mutations21 topic
- Preoperative Chemoradiotherapy21 topic
- Sunitinib21 topic
- Targeted Therapy21 topic
- Cushing's Syndrome11 topic
- Dermatological Toxicity11 topic
- Dual-Energy CT11 topic
- Extravasation11 topic
- Material Differentiation11 topic
- Pituitary Adenomas11 topic
Where does U. Fink work?
U. Fink's main affiliation in the publication record is TUM Klinikum, Germany.
How many publications and citations does U. Fink have?
Science Explorer counts 18 works and 11 citations for U. Fink, ranking #1,234,025 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named U. Fink
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.